15 October 2024

2024 Houston Cholangiocarcinoma Symposium


The 2024 Houston Cholangiocarcinoma Symposium will be held on Friday, December 13, from 9 a.m. to 3 p.m. This event is an opportunity to connect with others affected by cholangiocarcinoma, meet leading experts in the field, and engage in meaningful discussions. 

The event is designed to provide a comprehensive overview of the latest advancements in cholangiocarcinoma treatment and research and give providers, patients, and caregivers an inside look at treatments, advancements, and resources. Attendees can ask questions directly of experts during panel discussions and network with other patients, caregivers, and healthcare professionals.

Details

  • December 13, 2024
  • 9 a.m. – 3 p.m.
  • Onstead Auditorium (3rd Floor)
  • 6767 Bertner Ave, Houston, Texas 77030

Why Attend?

  • Network with providers, experts, and individuals and families who share similar experiences
  • Learn from leading experts about the latest advancements in cholangiocarcinoma treatment.
  • Engage in interactive Q&A sessions and panel discussions
  • Gain insights into both systemic and non-systemic therapies

Join us for a day of education, support, and community. Your participation is crucial in fostering a stronger network for those impacted by cholangiocarcinoma.

The Houston Symposium will be an in-person-only event. To ensure an inclusive experience, translation services will be available. If you require translation assistance, please indicate your needs on the registration form. This will help us accommodate everyone and provide the necessary support during the symposium.

Register for this free event here to ensure your spot.

12 October 2024

Adam Abeshouse dies at 63 from Bile Duct Cancer

Adam Abeshouse's clients joined him at the studio adjacent to his home for a farewell concert. Joshua Bell, first row, from left, Adam Abeshouse, Larisa Martinez and Kevin Puts. And, second row, from left, John-Henry Crawford, Charles Yang, Peter Dugan, Lara Downes, Ranaan Meyer, Garrick Ohlsson, Jeremy Denk, Nicolas Kendall and Simone Dinnerstein. NPR.

Early in 2024, Adam Abeshouse was diagnosed with bile duct cancer, and the disease swiftly metastasized. He was a producer who inspired great love and loyalty with the artists he worked with. Shortly before the end of his life, a dozen of his celebrity clients came together to perform for Abeshouse one last time, in a private concert at his home studio.

"In 2002, Adam Abeshouse founded the Classical Recording Foundation to help artists record music they were passionate about but might not have economic appeal. Because he said, “Recordings are just as important an art form as live performance."

A force that will be missed, but a strong legacy that lives on. RIP, Adam Abeshouse.

07 October 2024

Cholangiocarcinoma Foundation Webinar

 

Mark Yarchoan, MD Johns Hopkins University
Mark Yarchoan, MD
Johns Hopkins University

This webinar will introduce an upcoming clinical trial at Johns Hopkins, led by Drs. Marina Baretti, Nilo Azad, and Mark Yarchoan.

The trial focuses on a therapeutic vaccine designed to boost the effectiveness of standard immunotherapy drugs for cholangiocarcinoma. Dr. Yarchoan will present information about the vaccine and provide a broader overview of how therapeutic cancer vaccines have evolved.


The discussion will cover past challenges, recent breakthroughs (including successes with vaccines in other types of cancer), and how these advancements could shape future cancer treatments.


Thursday, October 10, 2024

4:00pm (EDT)


Register now.